Metabolic networks in Parkinson's disease

Mechanisms and Emerging Therapies in Tremor Disorders

Volumn , Issue , 2013, Pages 403-415

  Pourfar, Michael ^a   Niethammer, Martin ^a   Eidelberg, David ^b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Atypical parkinsonian syndromes; Cortico striato pallidal thalamocortical circuits; Metabolic networks; Motor; Parkinson's disease; Patterns

Indexed keywords

EID: 84940392040     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4027-7_22     Document Type: Chapter

References (53)

1. Albin RL, Koeppe RA, Chervin RD, Consens FB, Wernette K, Frey KA, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 2000;55(9):1410-2.
2. Alexander GE, Moeller JR. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: A principal component approach to modeling brain function in disease. Hum Brain Mapp. 1994;2:1-16.
3. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res. 1990;85:119-46.
4. Antonini A, Moeller JR, Nakamura T, Spetsieris P, Dhawan V, Eidelberg D. The metabolic anatomy of tremor in Parkinson's disease. Neurology. 1998;51(3):803-10.
5. Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, et al. Network modulation in the treatment of Parkinson's disease. Brain. 2006;129(Pt 10):2667-78.
6. Benamer HT, Oertel WH, Patterson J, Hadley DM, Pogarell O, Hoffken H, et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders:Part 1. Baseline and 3-month observations. Mov Disord. 2003;18(9):977-84.
7. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol. 2004;17(3):146-57.
8. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130 (Pt 11):2770-88.
9. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24(2):197-211.
10. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007;22(9):1272-7.
11. Deiber MP, Pollak P, Passingham R, Landais P, Gervason C, Cinotti L, et al. Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain. 1993;116(Pt 1):267-79.
12. Eckert T, Edwards C. The application of network mapping in differential diagnosis of parkinsonian disorders. Clin Neurosci Res. 2007;6:359-66.
13. Eckert T, Van Laere K, Tang C, Lewis DE, Edwards C, Santens P, et al. Quantification of Parkinson's disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging. 2007;34(4):496-501.
14. Eckert T, Tang C, Ma Y, Brown N, Lin T, Frucht S, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord. 2008;23(5):727-33.
15. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci. 2009;32(10):548-57.
16. Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, et al. Assessment of disease severity in parkinsonism withfluorine-18-fluorodeoxyglucose and PET. J Nucl Med. 1995; 36(3):378-83.
17. Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, et al. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain. 1997;120(Pt 8):1315-24.
18. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain. 2000;123(Pt 6):1155-60.
19. Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, et al. Tc-99 m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord. 2002;17(6):1265-70.
20. Feigin A, Tang C, Ma Y, Mattis P, Zgaljardic D, Guttman M, et al. Thalamic metabolism and symptom onset in preclinical Huntington's disease. Brain. 2007a;130(Pt 11):2858-67.
21. Feigin A, Kaplitt MG, Tang C, Lin T, Mattis P, Dhawan V, et al. Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA. 2007b;104(49):19559-64.
22. Fukuda M, Barnes A, Simon ES, Holmes A, Dhawan V, Giladi N, et al. Thalamic stimulation for parkinsonian tremor: Correlation between regional cerebral bloodflow and physiological tremor characteristics. Neuroimage. 2004;21(2):608-15.
23. Habeck C, Stern Y. Multivariate data analysis for neuroimaging data: Overview and application to Alzheimer's disease. Cell Biochem Biophys. 2010;58(2):53-67.
24. Habeck C, Krakauer JW, Ghez C, Sackeim HA, Eidelberg D, Stern Y, et al. A new approach to spatial covariance modeling of functional brain imaging data: Ordinal trend analysis. Neural Comput. 2005;17(7):1602-45.
25. Hirano S, Asanuma K, Ma Y, Tang C, Feigin A, Dhawan V, et al. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease. J Neurosci. 2008; 28(16):4201-9.
26. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, et al. Changes in network activity with the progression of Parkinson's disease. Brain. 2007a;130(Pt 7):1834-46.
27. Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage. 2007b;34(2):714-23.
28. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology. 2008;70(16 Pt 2):1470-7.
29. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 1993;50(2):140-8.
30. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125(Pt 4):861-70.
31. Isaias IU, Marotta G, Hirano S, Canesi M, Benti R, Righini A, et al. Imaging essential tremor. Mov Disord. 2010;25(6):679-86.
32. Lin TP, Carbon M, Tang C, Mogilner AY, Sterio D, Beric A, et al. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain. 2008;131(Pt 5):1373-80.
33. Ma Y, Eidelberg D. Functional imaging of cerebral bloodflow and glucose metabolism in Parkinson's disease and Huntington's disease. Mol Imaging Biol. 2007;9(4):223-33.
34. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D. Abnormal metabolic network activity in Parkinson's disease: Test-retest reproducibility. J Cereb Blood Flow Metab. 2007;27(3):597-605.
35. Ma Y, Huang C, Dyke JP, Pan H, Alsop D, Feigin A, et al. Parkinson's disease spatial covariance pattern: Noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab. 2010;30(3):505-9.
36. Mattis PJ, Tang CC, Ma Y, Dhawan V, Eidelberg D. Network correlates of the cognitive response to levodopa in Parkinson disease. Neurology. 2011;77(9):858-65.
37. Melzer TR, Watts R, MacAskill MR, Pearson JF, Rueger S, Pitcher TL, et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain. 2011;134(Pt 3):845-55.
38. Moeller JR, Strother SC. A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab. 1991;11(2):A121-35.
39. Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, et al. Reproducibility of regional metabolic covariance patterns: Comparison of four populations. J Nucl Med. 1999;40(8):1264-9.
40. Mure H, Hirano S, Tang CC, Isaias IU, Antonini A, Ma Y, et al. Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects. Neuroimage. 2011; 54(2):1244-53.
41. Niethammer M, Tang CC, Poston KL, Feigin A, Eidelberg D. An abnormal metabolic network in corticobasal degeneration. Neurology. 2011;76 Suppl 4:A640.
42. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal gangliathalamo- cortical loop. Brain Res Brain Res Rev. 1995;20(1):91-127.
43. Parker F, Tzourio N, Blond S, Petit H, Mazoyer B. Evidence for a common network of brain structures involved in parkinsonian tremor and voluntary repetitive movement. Brain Res. 1992; 584(1-2):11-7.
44. Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel J-P, et al. Network correlates of disease severity in multiple system atrophy. Neurology. 2012;78(16):1237-44.
45. Riedel O, Klotsche J, Spottke A, Deuschl G, Forstl H, Henn F, et al. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD). J Neurol. 2008;255(2):255-64.
46. Schrag A, Ben-Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study. Lancet. 1999;354(9192):1771-5.
47. Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues. Neuroimage. 2011;54(4):2899-914.
48. Spetsieris PG, Ma Y, Dhawan V, Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage. 2009;45(4):1241-52.
49. Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2005; 128(Pt 1):126-37.
50. Tang CC, Poston KL, Dhawan V, Eidelberg D. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci. 2010a;30(3):1049-56.
51. Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, et al. Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis. Lancet Neurol. 2010b; 9(2):149-58.
52. Trost M, Su S, Su P, Yen RF, Tseng HM, Barnes A, et al. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage. 2006;31(1):301-7.
53. Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto M, Aida S, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology. 1995;45(4):709-12.